An interventional study of OXYGEN THERAPY in Gastric Disease and Gastric Distress, sponsored by Inonu University. Not yet recruiting at 1 site in Turkey. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2024-02-22.
Sponsored by Inonu University · Not applicable, Interventional, and Treatment
To compare desaturation and respiratory complications by applying oxygen therapy with double nasal cannula to patients who are planned to undergo gastrointestinal endoscopy.
Two groups of patients scheduled for gastrointestinal endoscopy will be compared in terms of desaturation and respiratory complications by applying 15 litres of oxygen therapy to the first group and 30 litres to the second group with double nasal cannula.
53 studies on the registry are indexed under Stomach Diseases; 6 are open to participants now.
This study's planned enrollment of 200 is above the median of 75 across 39 interventional studies indexed under Stomach Diseases.
Browse Stomach Diseases studies →Inonu University is the lead sponsor of 394 studies on the registry; 95 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
18-65 years old
PATIENTS WHO WILL HAVE ENDOSCOPY AND OR COLONOSCOPY
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
COPD
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
: Patients who will receive 15 litres oxygen therapy, will be applied throughout the transaction.Patient saturation and complications such as bronchospasm and laryngospasm respiratory arrest will be recorded throughout the procedure.
Drug: OXYGEN THERAPY
Patients who will receive 30 litres oxygen therapy,will be applied throughout the transaction.Patient saturation and complications such as bronchospasm and laryngospasm respiratory arrest will be recorded throughout the procedure.
Drug: OXYGEN THERAPY
15 AND 30 LT OXYGEN TREATMENT
Determination of the amount of oxygen to prevent the peripheral oxygen saturation of the patients from falling below 95%
Determination of the amount of oxygen to prevent the peripheral oxygen saturation of the patients from falling below 95%
Time frame: Up to 24 weeks
Start is estimated for Mar 2024; primary completion for May 2024, 1 month later.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.